Eli Lilly and Company
Rapid-acting insulin compositions
Last updated:
Abstract:
The invention is a composition of insulin or insulin analog that has faster pharmacokinetic action than commercial formulations of rapid-onset insulin analog products.
Status:
Grant
Type:
Utility
Filling date:
31 May 2018
Issue date:
28 Dec 2021